CAP-T
Live / Registered — International registration cancelled — extension of protection cancelled (as of 11 May 2020)
What this means for you
Registered since 11 Oct 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79084150
- Registration number
- 4036922
- Mark type
- Stylized text
- Filed
- 11 May 2010
- Published for opposition
- 26 Jul 2011
- Registered
- 11 Oct 2011
- Attorney of record
- Jeffrey H. Kamenetsky
Goods and services
- Class 001 — Chemicals: Chemical, biological and biochemical additives, preparations and reagents for use in the manufacture of chemicals, biologicals and biochemicals, namely, preparations and reagents for non medical use, in particular for scientific, research, laboratory, industrial and commercial purposes; chemical, biological and biochemical additives, preparations and reagents for research and characterisation of diseases for non-medical purposes; chemical, biological and biochemical additives, preparations and reagents, namely, cell lines, cells, proteins and polypeptides, for scientific and medical research and development of pharmaceuticals; chemical, biological and biochemical additives, preparations and reagents for use in the manufacture of medicines and pharmaceuticals; cultures of microorganisms other than for medical and veterinary use; cell lines, cells and amino acids for laboratory or research use; nucleic acid sequences, proteins and polypaptides for other than medical and veterinary use; diagnostic reagents and preparations comprising proteins, polypeptides, nucleotides, nucleic acids, cell lines and cells for scientific, research, laboratory, and commercial purposes for the development of medicines and for use in the manufacture of medicines and pharmaceuticals
- Class 005 — Pharmaceuticals: Medicines, chemical, biological and biochemical preparations and proteins for the treatment of cancer, tumourous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardiovascular diseases, except thyreostatica and cough and cold medicines; pharmaceutical and veterinary preparations and reagents for use in the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except thyreostatica and cough and cold medicines; chemical, biological and biochemical reagents for medical and veterinary purposes, except thyreostatica and cough and cold medicines; diagnostic and analytic preparations for medical and veterinary purposes; cell lines, cells, diagnostic proteins and polypeptides for medical or clinical use; nucleic acid sequences, diagnostic proteins, polypeptides and chemical reagents for medical and veterinary purposes; amino acids for medical or veterinary purposes; diagnostic reagents and preparations, namely, microorganisms, proteins, polypeptides, nucleotides, nucleic acids, cell lines and cells for medical, veterinary and diagnostic purposes, except thyreostatica and cough and cold medicines
- Class 042 — Scientific and technological services: Scientific and industrial research, namely, in the fields of medicine, pharmaceuticals, molecular biology, biotechnology, immunology and genetics; research and development of medicines, diagnostic and analytic preparations, methods of therapy and expression systems; scientific and technological consulting services, namely, in the fields of medicine, pharmaceuticals, molecular biology, biotechnology, immunology and genetics; industrial consulting services, namely, consultancy pertaining to pharmacology; breeding, recovery, optimisation, synthesis and modification of cell culture lines, cells, microorganisms, polypeptides, proteins, nucleotides, nucleic acids for scientific, research, laboratory, industrial and commercial purposes, namely, for use in the fields of medicine, pharmaceuticals, molecular biology, biotechnology, immunology and genetics, for the development of medicines and for use in the manufacture of medicines and pharmaceuticals
Owner
- CEVEC Pharmaceuticals GmbH, 51105 Köln, DE
- CEVEC Pharmaceuticals GmbH, 51105 Köln, DE
- CEVEC Pharmaceuticals GmbH, 51105 Köln, DE
Prosecution history
- 29 May 2021 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 29 May 2021 — DEATH OF INTERNATIONAL REGISTRATION
- 15 Mar 2019 — TOTAL INVALIDATION PROCESSED BY THE IB
- 28 Jan 2019 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 28 Jan 2019 — INVALIDATION PROCESSED
- 18 Jan 2019 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 18 May 2018 — CANCELLED SECTION 71
- 11 Jun 2012 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 May 2012 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 May 2012 — FINAL DISPOSITION PROCESSED
- 11 Jan 2012 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Nov 2011 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 29 Oct 2011 — LIMITATION OF GOODS RECEIVED FROM IB
- 11 Oct 2011 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED